Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 59

Therapeutics

Mayo Clinic sequenced 100K participants to build genomic database for improved care and research in collaboration with Helix
Biotechnology | Diagnostics | Genomics | Non-Profit Research | Therapeutics

Mayo Clinic sequenced 100K participants to build genomic database for improved care and research in collaboration with Helix

On Jan. 9, 2020, Mayo Clinic announced it was creating a library of genomic sequencing data on 100,000…

Read More Mayo Clinic sequenced 100K participants to build genomic database for improved care and research in collaboration with HelixContinue

Penn Medicine birth marked a milestone in uterus transplant clinical trial
Biotechnology | Non-Profit Research | Therapeutics | Women's Health

Penn Medicine birth marked a milestone in uterus transplant clinical trial

On Jan. 9, 2020, Penn Medicine announced the birth of Benjamin Thomas Gobrecht: his mother, 33-year-old Jennifer Gobrecht,…

Read More Penn Medicine birth marked a milestone in uterus transplant clinical trialContinue

O’Neal Cancer Center welcomed Sleckman as new director
Diagnostics | Medicine | Non-Profit Research | Therapeutics

O’Neal Cancer Center welcomed Sleckman as new director

On Jan. 8, 2020, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that world-renowned researcher…

Read More O’Neal Cancer Center welcomed Sleckman as new directorContinue

Xencor and Gilead entered license agreement for use of XmAb antibody technologies in investigational agents for HIV
Biotechnology | HIV | Therapeutics

Xencor and Gilead entered license agreement for use of XmAb antibody technologies in investigational agents for HIV

On Jan. 8, 2020, Xencor announced a technology license agreement in which Gilead Sciences will access Xencor’s Xtend…

Read More Xencor and Gilead entered license agreement for use of XmAb antibody technologies in investigational agents for HIVContinue

FDA approved 3D-printed airway stents developed by Cleveland Clinic doctor
FDA | Medical Device | Therapeutics

FDA approved 3D-printed airway stents developed by Cleveland Clinic doctor

On Jan. 8, 2020, the U.S. Food and Drug Administration (FDA) approved patient-specific airway stents developed by Cleveland…

Read More FDA approved 3D-printed airway stents developed by Cleveland Clinic doctorContinue

Thomas J. Lynch Jr became the sixth president of the Fred Hutchinson Cancer Research Center
Biotechnology | Diagnostics | Medicine | Non-Profit Research | Therapeutics

Thomas J. Lynch Jr became the sixth president of the Fred Hutchinson Cancer Research Center

On Jan. 7, 2020, the Fred Hutchinson Cancer Research Center announced Dr. Thomas J. Lynch Jr. as the…

Read More Thomas J. Lynch Jr became the sixth president of the Fred Hutchinson Cancer Research CenterContinue

Karmanos Cancer Institute received the 2020 Women’s Choice Award
Biotechnology | Oncology | Therapeutics | Women's Health

Karmanos Cancer Institute received the 2020 Women’s Choice Award

On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…

Read More Karmanos Cancer Institute received the 2020 Women’s Choice AwardContinue

The FDA approved new treatment option for patients with HER2-positive breast cancer
Biotechnology | FDA | Oncology | Therapeutics | Women's Health

The FDA approved new treatment option for patients with HER2-positive breast cancer

On Dec. 20, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Daiichi Sankyo’s Enhertu…

Read More The FDA approved new treatment option for patients with HER2-positive breast cancerContinue

Dr. Pedro Rosa-Neto announced the discovery that the protein APOEᅠꜫ4 ᅠplays a central role in Alzheimer’s disease
Biotechnology | Diagnostics | Neurology | Therapeutics

Dr. Pedro Rosa-Neto announced the discovery that the protein APOEᅠꜫ4 ᅠplays a central role in Alzheimer’s disease

On Dec. 20, 2019, Dr. Pedro Rosa-Neto announced the discovery that the protein APOEꜫ4 plays a central role…

Read More Dr. Pedro Rosa-Neto announced the discovery that the protein APOEᅠꜫ4 ᅠplays a central role in Alzheimer’s diseaseContinue

The Jackson Laboratory received $2.5  million from The Mark Foundation for breakthrough cancer immunotherapy project
Biotechnology | Non-Profit Research | Therapeutics

The Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy project

On Dec. 18, 2019, the Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy…

Read More The Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy projectContinue

FDA granted accelerated approval to Astellas and Seagen PADCEV for people with locally advanced or metastatic urothelial cancer
Biotechnology | FDA | Therapeutics

FDA granted accelerated approval to Astellas and Seagen PADCEV for people with locally advanced or metastatic urothelial cancer

On Dec. 18, 2019, Seagen and Astellas Pharma announced the U.S. Food and Drug Administration (FDA) had granted…

Read More FDA granted accelerated approval to Astellas and Seagen PADCEV for people with locally advanced or metastatic urothelial cancerContinue

Pediatric brain tumor treatment at the University of Alabama awarded FDA grant for first-in-human study
Biotechnology | FDA | Neurology | Therapeutics

Pediatric brain tumor treatment at the University of Alabama awarded FDA grant for first-in-human study

On Dec. 17, 2019, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) announced that Gregory Friedman,…

Read More Pediatric brain tumor treatment at the University of Alabama awarded FDA grant for first-in-human studyContinue

Researchers at Vanderbilt University Medical Center isolated an antibody that blocks bird flu
Biotechnology | Influenza | Therapeutics

Researchers at Vanderbilt University Medical Center isolated an antibody that blocks bird flu

On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…

Read More Researchers at Vanderbilt University Medical Center isolated an antibody that blocks bird fluContinue

BioAegis announced publication: ‘Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza’
Biotechnology | Influenza | Therapeutics

BioAegis announced publication: ‘Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza’

On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…

Read More BioAegis announced publication: ‘Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza’Continue

Oregonian received life-saving heart valve repair without open-heart surgery
Cardiology | Medical Device | Non-Profit Research | Therapeutics

Oregonian received life-saving heart valve repair without open-heart surgery

On Dec. 11, 2019, Dennis Eggers became the first patient in a new clinical trial to receive a…

Read More Oregonian received life-saving heart valve repair without open-heart surgeryContinue

PATH announced Nikolaj Gilbert as President and CEO
Biotechnology | Diagnostics | HIV | Non-Profit Research | Therapeutics

PATH announced Nikolaj Gilbert as President and CEO

On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…

Read More PATH announced Nikolaj Gilbert as President and CEOContinue

Nanomix received CE Mark for diagnostic panel that aids in rapid identification of life-threatening infections
Diagnostics | Life Science History | Therapeutics

Nanomix received CE Mark for diagnostic panel that aids in rapid identification of life-threatening infections

On Dec. 4. 2019, US-based Nanomix announced that the company had received CE Mark for its S1 Assay…

Read More Nanomix received CE Mark for diagnostic panel that aids in rapid identification of life-threatening infectionsContinue

The Cold Spring Harbor Laboratory researchers identified gene behind spread of deadly breast cancer
Biotechnology | Disease | Oncology | Therapeutics

The Cold Spring Harbor Laboratory researchers identified gene behind spread of deadly breast cancer

On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…

Read More The Cold Spring Harbor Laboratory researchers identified gene behind spread of deadly breast cancerContinue

FDA approved new sickle cell treatment based on clincal trial results from UTHSC’s Kenneth Ataga, MD
Clinical Research | Disease | FDA | Non-Profit Research | Therapeutics

FDA approved new sickle cell treatment based on clincal trial results from UTHSC’s Kenneth Ataga, MD

On Dec. 2, 2019, the U.S. Food and Drug Administration (FDA) announced it had approved the drug crizanlizumab…

Read More FDA approved new sickle cell treatment based on clincal trial results from UTHSC’s Kenneth Ataga, MDContinue

SEHA, Mayo Clinic entered joint venture to operate Sheikh Shakhbout Medical City in the United Arab Emirates
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Therapeutics

SEHA, Mayo Clinic entered joint venture to operate Sheikh Shakhbout Medical City in the United Arab Emirates

On Nov. 24, 2019, Abu Dhabi Health Services Company, the largest healthcare network in the United Arab Emirates…

Read More SEHA, Mayo Clinic entered joint venture to operate Sheikh Shakhbout Medical City in the United Arab EmiratesContinue

UCSD researchers provided new insights into a key pathway that controls critical cell division mechanisms
Biotechnology | Disease | Non-Profit Research | Therapeutics

UCSD researchers provided new insights into a key pathway that controls critical cell division mechanisms

On Nov. 20, 2019, University of California San Diego (UCSD) researchers provided new insights into a key pathway…

Read More UCSD researchers provided new insights into a key pathway that controls critical cell division mechanismsContinue

The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grants
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics

The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grants

On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its…

Read More The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grantsContinue

Celgene acquired by Bristol-Myers Squibb
Biotechnology | Therapeutics

Celgene acquired by Bristol-Myers Squibb

On Nov. 20, 2019. Bristol-Myers Squibb announced it had completed its acquisition of Celgene. On Jun. 29, 2015,…

Read More Celgene acquired by Bristol-Myers SquibbContinue

Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of the Novo Broad Greenhouse
Biotechnology | Medicine | Non-Profit Research | Therapeutics

Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of the Novo Broad Greenhouse

On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of…

Read More Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of the Novo Broad GreenhouseContinue

Amgen and Duke Clinical Research Institute initiated first large-scale registry to evaluate real-world lipid management
Biotechnology | Therapeutics

Amgen and Duke Clinical Research Institute initiated first large-scale registry to evaluate real-world lipid management

On Nov. 15, 2019, Amgen in collaboration with the Duke Clinical Research Institute (DCRI) announced plans to initiate…

Read More Amgen and Duke Clinical Research Institute initiated first large-scale registry to evaluate real-world lipid managementContinue

Researchers at UCSD School of Medicine successfully applied phage therapy in mice to treat alcohol-related liver disease
Biotechnology | Disease | Non-Profit Research | Therapeutics

Researchers at UCSD School of Medicine successfully applied phage therapy in mice to treat alcohol-related liver disease

On Nov. 13, 2019, researchers at University of California San Diego (UCSD) School of Medicine announced that they…

Read More Researchers at UCSD School of Medicine successfully applied phage therapy in mice to treat alcohol-related liver diseaseContinue

Merck acquired San Diego’s Calporta for up to $576 million
Biotechnology | Pharmaceutical | Therapeutics

Merck acquired San Diego’s Calporta for up to $576 million

On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…

Read More Merck acquired San Diego’s Calporta for up to $576 millionContinue

Abbott announced discovery of a new strain of HIV
Biotechnology | CDC | Diagnostics | Genomics | HIV | Therapeutics

Abbott announced discovery of a new strain of HIV

On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…

Read More Abbott announced discovery of a new strain of HIVContinue

Karmanos Cancer Institute established the McLaren Proton Therapy Center
Biotechnology | Diagnostics | Neurology | Non-Profit Research | Oncology | Radiology | Therapeutics

Karmanos Cancer Institute established the McLaren Proton Therapy Center

On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…

Read More Karmanos Cancer Institute established the McLaren Proton Therapy CenterContinue

Researchers at UGA’s Center for the Ecology of Infectious Diseases received a $16 million grant to study tropical diseases
Biotechnology | Disease | Therapeutics | Vaccine

Researchers at UGA’s Center for the Ecology of Infectious Diseases received a $16 million grant to study tropical diseases

On Oct. 30, 2019, researchers at the University of Georgia’s Center for the Ecology of Infectious Diseases received…

Read More Researchers at UGA’s Center for the Ecology of Infectious Diseases received a $16 million grant to study tropical diseasesContinue

Page navigation

Previous PagePrevious 1 … 57 58 59 60 61 … 117 Next PageNext
  • Categories
  • Timeline
  • Aesthetics
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Olfactory
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Quantum
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1761
  • 1755
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1710
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Digital Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2026 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search